Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in

It has been over a year since people with multiple sclerosis (pwMS) have been receiving vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With a negligible number of cases in which vaccination led to a relapse or new onset MS, experts around the world agree that the pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Pugliatti, Maura, Hartung, Hans-Peter, Oreja-Guevara, Celia, Pozzilli, Carlo, Airas, Laura, Alkhawajah, Mona, Grigoriadis, Nikolaos, Magyari, Melinda, Van Wijmeersch, Bart, Zakaria, Magd, Linker, Ralf, Chan, Andrew, Vermersch, Patrick, Berger, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620960/
https://www.ncbi.nlm.nih.gov/pubmed/36325318
http://dx.doi.org/10.3389/fimmu.2022.1045101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620960/
https://www.ncbi.nlm.nih.gov/pubmed/36325318
http://dx.doi.org/10.3389/fimmu.2022.1045101

Ejemplares similares